Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum Malaria
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
We will be studying the clinical efficacy of amodiaquine-artesunate currently being studied
in an intermittent preventive therapy in infants (IPTi)trial in the same area in order to
correlate preventive efficacy seen in IPTi with efficacy for treatment of symptomatic malaria
for each regimen.
Phase:
Phase 4
Details
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborators:
Kenya Medical Research Institute London School of Hygiene and Tropical Medicine